Chinese Expert Consensus on Prevention and Intervention for Elderly with Sarcopenia (2023)

Overview

Journal Aging Med (Milton)

Specialty Geriatrics

Date 2023 Jun 8

PMID 37287669

Authors

Hua Cui

Zhaohui Wang

Jianqing Wu

Ying Liu

Jin Zheng

Wenkai Xiao

Ping He

Yun Zhou

Jianye Wang

Pulin Yu

Cuntai Zhang

Jinhui Wu

Affiliations

Soon will be listed here.

Abstract

Sarcopenia is the age-related loss of skeletal muscle mass and muscle strength or physical function. It is most common in elderly individuals. Due to its high incidence, insidious onset, and extensive impact on the body, it has a huge impact on the family medical burden and the social public health expenditure in China. The understanding of sarcopenia in China is still lacking, and the recommendations for prevention, control, and intervention are not clear and unified. The purpose of this consensus report is to standardize the prevention, control, and intervention methods for sarcopenia in elderly patients in China; improve the efficacy of intervention; reduce complications during the intervention process; and reduce the risk of falls, fractures, disability, hospitalization, and even death in elderly individuals.

Citing Articles

Sex differences in the associations of dietary protein intake with lean mass and grip strength in children and adolescents.

Wang Y, Sun D, Zhu Z J Int Soc Sports Nutr. 2025; 22(1):2471471.

PMID: 39994891 PMC: 11864004. DOI: 10.1080/15502783.2025.2471471.

Opportunistic muscle density assay during CT lung cancer screening for low muscle quality evaluation in older adults: a multicenter study.

Chen X, Gao X, Wang R, Wei Z, Wang J, Wang M Aging Clin Exp Res. 2025; 37(1):41.

PMID: 39985725 PMC: 11846760. DOI: 10.1007/s40520-025-02933-9.

Risk factors of stroke-related sarcopenia: a systematic review and meta-analysis.

Yan H, Li J, Xian L, Li Y, Li S, Wen Q Front Aging. 2025; 6:1452708.

PMID: 39967995 PMC: 11833335. DOI: 10.3389/fragi.2025.1452708.

Prospects for the diagnosis and treatment of sarcopenia in the Philippines.

Sun J, Zhang W, Han P Front Med (Lausanne). 2025; 11():1501501.

PMID: 39839628 PMC: 11747553. DOI: 10.3389/fmed.2024.1501501.

Development and validation of a screening tool for sarcopenia in Chinese nursing home residents.

Sun K, Wu X, Yu J, Chen W, Jia X, Li D iScience. 2024; 27(11):111221.

PMID: 39569363 PMC: 11577178. DOI: 10.1016/j.isci.2024.111221.

References

Cruz-Jentoft A, Landi F, Schneider S, Zuniga C, Arai H, Boirie Y . Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014; 43(6):748-59. PMC: 4204661. DOI: 10.1093/ageing/afu115. View

Taniguchi Y, Kitamura A, Seino S, Murayama H, Amano H, Nofuji Y . Gait Performance Trajectories and Incident Disabling Dementia Among Community-Dwelling Older Japanese. J Am Med Dir Assoc. 2017; 18(2):192.e13-192.e20. DOI: 10.1016/j.jamda.2016.10.015. View

Xu D, Hong Y, Li J, Chan K . Effect of tai chi exercise on proprioception of ankle and knee joints in old people. Br J Sports Med. 2004; 38(1):50-4. PMC: 1724726. DOI: 10.1136/bjsm.2002.003335. View

Liang Y, Wang R, Jiang J, Tan L, Yang M . A randomized controlled trial of resistance and balance exercise for sarcopenic patients aged 80-99 years. Sci Rep. 2020; 10(1):18756. PMC: 7603310. DOI: 10.1038/s41598-020-75872-2. View

Jorm A . Using the Delphi expert consensus method in mental health research. Aust N Z J Psychiatry. 2015; 49(10):887-97. DOI: 10.1177/0004867415600891. View

Hutchins-Wiese H, Kleppinger A, Annis K, Liva E, Lammi-Keefe C, Durham H . The impact of supplemental n-3 long chain polyunsaturated fatty acids and dietary antioxidants on physical performance in postmenopausal women. J Nutr Health Aging. 2013; 17(1):76-80. DOI: 10.1007/s12603-012-0415-3. View

Ritch C, Cookson M, Clark P, Chang S, Fakhoury K, Ralls V . Perioperative Oral Nutrition Supplementation Reduces Prevalence of Sarcopenia following Radical Cystectomy: Results of a Prospective Randomized Controlled Trial. J Urol. 2018; 201(3):470-477. DOI: 10.1016/j.juro.2018.10.010. View

Uchitomi R, Oyabu M, Kamei Y . Vitamin D and Sarcopenia: Potential of Vitamin D Supplementation in Sarcopenia Prevention and Treatment. Nutrients. 2020; 12(10). PMC: 7603112. DOI: 10.3390/nu12103189. View

Dhillon R, Hasni S . Pathogenesis and Management of Sarcopenia. Clin Geriatr Med. 2016; 33(1):17-26. PMC: 5127276. DOI: 10.1016/j.cger.2016.08.002. View

10.

Reginster J, Beaudart C, Al-Daghri N, Avouac B, Bauer J, Bere N . Update on the ESCEO recommendation for the conduct of clinical trials for drugs aiming at the treatment of sarcopenia in older adults. Aging Clin Exp Res. 2020; 33(1):3-17. PMC: 7897619. DOI: 10.1007/s40520-020-01663-4. View

11.

Troesch B, Eggersdorfer M, Laviano A, Rolland Y, Smith A, Warnke I . Expert Opinion on Benefits of Long-Chain Omega-3 Fatty Acids (DHA and EPA) in Aging and Clinical Nutrition. Nutrients. 2020; 12(9). PMC: 7551800. DOI: 10.3390/nu12092555. View

12.

Tan K, Ang S, Tsai S . Sarcopenia: Tilting the Balance of Protein Homeostasis. Proteomics. 2019; 20(5-6):e1800411. DOI: 10.1002/pmic.201800411. View

13.

Chen L, Woo J, Assantachai P, Auyeung T, Chou M, Iijima K . Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020; 21(3):300-307.e2. DOI: 10.1016/j.jamda.2019.12.012. View

14.

Beaudart C, Buckinx F, Rabenda V, Gillain S, Cavalier E, Slomian J . The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 2014; 99(11):4336-45. DOI: 10.1210/jc.2014-1742. View

15.

Shen S, Chu J, Cheng L, Zeng X, He T, Xu L . Effects of a nutrition plus exercise programme on physical function in sarcopenic obese elderly people: study protocol for a randomised controlled trial. BMJ Open. 2016; 6(9):e012140. PMC: 5051493. DOI: 10.1136/bmjopen-2016-012140. View

16.

Smith G, Julliand S, Reeds D, Sinacore D, Klein S, Mittendorfer B . Fish oil-derived n-3 PUFA therapy increases muscle mass and function in healthy older adults. Am J Clin Nutr. 2015; 102(1):115-22. PMC: 4480667. DOI: 10.3945/ajcn.114.105833. View

17.

Zhu L, Chan R, Kwok T, Cheng K, Ha A, Woo J . Effects of exercise and nutrition supplementation in community-dwelling older Chinese people with sarcopenia: a randomized controlled trial. Age Ageing. 2018; 48(2):220-228. DOI: 10.1093/ageing/afy179. View

18.

Janssen I, Shepard D, Katzmarzyk P, Roubenoff R . The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2003; 52(1):80-5. DOI: 10.1111/j.1532-5415.2004.52014.x. View

19.

De Spiegeleer A, Beckwee D, Bautmans I, Petrovic M . Pharmacological Interventions to Improve Muscle Mass, Muscle Strength and Physical Performance in Older People: An Umbrella Review of Systematic Reviews and Meta-analyses. Drugs Aging. 2018; 35(8):719-734. DOI: 10.1007/s40266-018-0566-y. View

20.

Yoshimura Y, Wakabayashi H, Yamada M, Kim H, Harada A, Arai H . Interventions for Treating Sarcopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Studies. J Am Med Dir Assoc. 2017; 18(6):553.e1-553.e16. DOI: 10.1016/j.jamda.2017.03.019. View